3.4.11.3 Abortion, Habitual http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16969009&form=6&db=m The Effectiveness of Adrenocorticotropin Repeated Doses in High Risk Pregnancies. diagnostic usage,unassigned 4,0 3.4.11.3 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11753524&form=6&db=m Comparison of periovulatory and early pregnancy blood levels of oxytocinase (CAP1) and isooxytocinase (CAP2). diagnostic usage,ongoing research,unassigned 4,2,0 3.4.11.3 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16136012&form=6&db=m Changes of maternal ACTH and oxytocinase plasma concentrations during the first trimester of spontaneous abortion. causal interaction,ongoing research,unassigned 4,2,0 3.4.11.3 Abortion, Threatened http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=727395&form=6&db=m [Thermostable alkaline phosphatase and oxytocinase activity in late-term threatened abortion] unassigned - 3.4.11.3 Abortion, Threatened http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1862862&form=6&db=m [Serum oxytocin and oxytocinase activities in women during pregnancy] diagnostic usage,ongoing research,unassigned 4,3,0 3.4.11.3 Abortion, Threatened http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14333236&form=6&db=m [INCREASE IN MATERNAL SERUM OXYTOCINASE LEVEL CAUSED BY ADMINISTRATION OF A GESTAGEN IN THREATENED ABORTION.] causal interaction,unassigned 3,0 3.4.11.3 Abruptio Placentae http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23393172&form=6&db=m Acute diabetes insipidus mediated by vasopressinase after placental abruption. causal interaction,unassigned 3,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1287035&form=6&db=m Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1292645&form=6&db=m Removal of gp160 induced bio-hazards for a safe AIDS vaccine candidate. causal interaction,therapeutic application,unassigned 4,3,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1305816&form=6&db=m Comparative evaluation of HIV infected foreign students and Indian with AIDS in Chandigarh, India. causal interaction,diagnostic usage,unassigned 2,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1353102&form=6&db=m Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,3,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1400960&form=6&db=m Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Network. diagnostic usage,ongoing research,therapeutic application,unassigned 1,4,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1457191&form=6&db=m Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins. causal interaction,unassigned 1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1534641&form=6&db=m Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 3,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1613672&form=6&db=m B-cell activation and differentiation by HIV-1 antigens among volunteers vaccinated with VaxSyn HIV-1. causal interaction,ongoing research,therapeutic application,unassigned 1,4,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1706607&form=6&db=m Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1845391&form=6&db=m Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1984386&form=6&db=m The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1993354&form=6&db=m Effect of a recombinant HIV gp160 vaccine on monokine production. ongoing research,therapeutic application,unassigned 2,4,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2092787&form=6&db=m Characteristics of a population volunteering for human immunodeficiency virus immunization. NIAID AIDS Clinical Trials Network. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2187503&form=6&db=m Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant gp160. causal interaction,ongoing research,therapeutic application,unassigned 2,2,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2990682&form=6&db=m Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3484980&form=6&db=m Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. unassigned - 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3497054&form=6&db=m Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects. diagnostic usage,unassigned 4,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7533680&form=6&db=m Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7625118&form=6&db=m HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7844247&form=6&db=m AIDS in Thailand: a medical student's perspective. therapeutic application,unassigned 1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7930718&form=6&db=m Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 2,3,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7944345&form=6&db=m DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies. diagnostic usage,ongoing research,unassigned 1,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7955519&form=6&db=m HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 1,3,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8095059&form=6&db=m Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. causal interaction,ongoing research,therapeutic application,unassigned 1,4,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8245523&form=6&db=m Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8292967&form=6&db=m HIV experimental vaccines based on the iscom technology using envelope and GAG gene products. diagnostic usage,unassigned 1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8370478&form=6&db=m Intracellular diversion of glycoprotein GP160 of human immunodeficiency virus to lysosomes as a strategy of AIDS gene therapy. causal interaction,ongoing research,therapeutic application,unassigned 2,2,4,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8578800&form=6&db=m Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. NIAID AIDS Vaccine Clinical Trials Network. causal interaction,ongoing research,therapeutic application,unassigned 2,2,2,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8627686&form=6&db=m Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. diagnostic usage,ongoing research,unassigned 3,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8892923&form=6&db=m A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells. diagnostic usage,therapeutic application,unassigned 3,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9144368&form=6&db=m Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group. ongoing research,therapeutic application,unassigned 3,3,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9176492&form=6&db=m Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. therapeutic application,unassigned 1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9491504&form=6&db=m Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. therapeutic application,unassigned 4,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10465068&form=6&db=m Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group. therapeutic application,unassigned 4,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11991964&form=6&db=m Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. ongoing research,therapeutic application,unassigned 1,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17721091&form=6&db=m Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges. ongoing research,therapeutic application,unassigned 3,1,0 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21544164&form=6&db=m HIV-1 envelope accessible surface and polarity: clade, blood, and brain. unassigned - 3.4.11.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25927639&form=6&db=m Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,4,0 3.4.11.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=442215&form=6&db=m VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung. causal interaction,therapeutic application,unassigned 2,1,0 3.4.11.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6625234&form=6&db=m [Cystine aminopeptidase activity is not a marker of ovarian adenocarcinoma] diagnostic usage,unassigned 1,0 3.4.11.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12684429&form=6&db=m Possible role of placental leucine aminopeptidase in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma. causal interaction,ongoing research,unassigned 3,4,0 3.4.11.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15907336&form=6&db=m Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 3.4.11.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16187279&form=6&db=m A novel role for placental leucine aminopeptidase (P-LAP) as a determinant of chemoresistance in endometrial carcinoma cells. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,3,1 3.4.11.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17233921&form=6&db=m P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,4,4 3.4.11.3 AIDS Dementia Complex http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10871768&form=6&db=m Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 AIDS-Related Complex http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1457191&form=6&db=m Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins. causal interaction,unassigned 1,0 3.4.11.3 AIDS-Related Complex http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3484980&form=6&db=m Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. unassigned - 3.4.11.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19126664&form=6&db=m The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease. causal interaction,therapeutic application,unassigned 4,4,0 3.4.11.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21348480&form=6&db=m Regulation of insulin-regulated membrane aminopeptidase activity by its C-terminal domain. causal interaction,therapeutic application,unassigned 3,4,0 3.4.11.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28069385&form=6&db=m Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer's disease. unassigned - 3.4.11.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33101040&form=6&db=m IRAP Inhibitors: M1-Aminopeptidase Family Inspiration. causal interaction,therapeutic application,unassigned 3,4,0 3.4.11.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33176650&form=6&db=m Putative Involvement of Endocrine Disruptors in the Alzheimer's disease Via the Insulin-Regulated Aminopeptidase / GLUT4 Pathway. unassigned - 3.4.11.3 Anthrax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15102434&form=6&db=m The kindest cuts of all: crystal structures of Kex2 and furin reveal secrets of precursor processing. unassigned - 3.4.11.3 Aortic Valve Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30581499&form=6&db=m Differential Gene Expression Profile of Renin-Angiotensin System in the Left Atrium in Mitral Regurgitation Patients. causal interaction,diagnostic usage,ongoing research,unassigned 3,1,2,0 3.4.11.3 Astrocytoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30370863&form=6&db=m Differential Effects of Doxazosin on Renin-Angiotensin-System-Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells. causal interaction,ongoing research,unassigned 1,4,0 3.4.11.3 Bacterial Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15847926&form=6&db=m Novel single-round PCR and cloning of full-length envelope genes of HIV-1 may yield new insight into biomolecular antibacterial drug development. causal interaction,therapeutic application,unassigned 3,4,0 3.4.11.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15234194&form=6&db=m Serum oxytocinase activity is related to tumor growth parameters in N-methyl nitrosourea induced rat breast cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,3,2 3.4.11.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16619500&form=6&db=m Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,3,0 3.4.11.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27834335&form=6&db=m A PCR-RFLP method for detection of the LNPEP encoding human insulin-regulated aminopeptidase (IRAP) rs4869317 polymorphism. therapeutic application,unassigned 2,0 3.4.11.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33158090&form=6&db=m Insulin-Regulated Aminopeptidase in Women with Breast Cancer: A Role beyond the Regulation of Oxytocin and Vasopressin. ongoing research,therapeutic application,unassigned 2,1,0 3.4.11.3 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15234194&form=6&db=m Serum oxytocinase activity is related to tumor growth parameters in N-methyl nitrosourea induced rat breast cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,3,2 3.4.11.3 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16619500&form=6&db=m Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,3,0 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3682513&form=6&db=m [Clinical evaluation of serum placental leucine aminopeptidase (P-LAP) activity in renal cell carcinoma] diagnostic usage,ongoing research,unassigned 4,4,0 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3723166&form=6&db=m Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma. causal interaction,therapeutic application,unassigned 3,4,0 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6534245&form=6&db=m [Markers of carcinoma of the ovary: serum cystine aminopeptidase and leucine aminopeptidase, reliable diagnostic parameters?] diagnostic usage,unassigned 4,0 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7474630&form=6&db=m [Expression of GP160 mRNA in renal cell carcinoma: an attempt to predict the sensitivity of IFN-alpha therapy] diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,3,0 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8346219&form=6&db=m Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. causal interaction,ongoing research,unassigned 1,3,0 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9568047&form=6&db=m Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,1 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9664120&form=6&db=m Aminopeptidase A expression and enzymatic activity in primary human renal cancers. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12684429&form=6&db=m Possible role of placental leucine aminopeptidase in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma. causal interaction,ongoing research,unassigned 3,4,0 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15218296&form=6&db=m Expression of placental leucine aminopeptidase is associated with a poor outcome in endometrial endometrioid adenocarcinoma. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,1 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15907336&form=6&db=m Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17373876&form=6&db=m Essential role of placental leucine aminopeptidase in gynecologic malignancy. causal interaction,ongoing research,unassigned 4,1,0 3.4.11.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17692401&form=6&db=m Cystinyl aminopeptidase activity is decreased in renal cell carcinomas. diagnostic usage,ongoing research,unassigned 3,3,0 3.4.11.3 Carcinoma, Endometrioid http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15218296&form=6&db=m Expression of placental leucine aminopeptidase is associated with a poor outcome in endometrial endometrioid adenocarcinoma. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,1 3.4.11.3 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34465271&form=6&db=m CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis. causal interaction,diagnostic usage,unassigned 3,1,0 3.4.11.3 Carcinoma, Renal Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3682513&form=6&db=m [Clinical evaluation of serum placental leucine aminopeptidase (P-LAP) activity in renal cell carcinoma] diagnostic usage,ongoing research,unassigned 4,4,0 3.4.11.3 Carcinoma, Renal Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7474630&form=6&db=m [Expression of GP160 mRNA in renal cell carcinoma: an attempt to predict the sensitivity of IFN-alpha therapy] diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,3,0 3.4.11.3 Carcinoma, Renal Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8346219&form=6&db=m Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. causal interaction,ongoing research,unassigned 1,3,0 3.4.11.3 Carcinoma, Renal Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9568047&form=6&db=m Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,1 3.4.11.3 Carcinoma, Renal Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17692401&form=6&db=m Cystinyl aminopeptidase activity is decreased in renal cell carcinomas. diagnostic usage,ongoing research,unassigned 3,3,0 3.4.11.3 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23897274&form=6&db=m Identification of a Missense Variant in LNPEP that Confers Psoriasis Risk. causal interaction,unassigned 3,0 3.4.11.3 Chagas Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30905022&form=6&db=m High-Level Expression in Escherichia coli, Purification and Kinetic Characterization of LAPTc, a Trypanosoma cruzi M17-Aminopeptidase. causal interaction,therapeutic application,unassigned 2,4,0 3.4.11.3 Cholera http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9203649&form=6&db=m Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG. ongoing research,unassigned 3,0 3.4.11.3 Chorioamnionitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12569180&form=6&db=m Interleukin-1beta stimulates placental leucine aminopeptidase/oxytocinase expression in BeWo choriocarcinoma cells. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11517297&form=6&db=m Transcriptional regulation of human placental leucine aminopeptidase/oxytocinase gene. ongoing research,unassigned 4,0 3.4.11.3 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11798181&form=6&db=m Ap-2 and Ikaros regulate transcription of human placental leucine aminopeptidase/oxytocinase gene. ongoing research,unassigned 3,0 3.4.11.3 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12569180&form=6&db=m Interleukin-1beta stimulates placental leucine aminopeptidase/oxytocinase expression in BeWo choriocarcinoma cells. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14527672&form=6&db=m Placental leucine aminopeptidase/oxytocinase gene regulation by activator protein-2 in BeWo cell model of human trophoblast differentiation. ongoing research,unassigned 4,0 3.4.11.3 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14691298&form=6&db=m Expression of placental leucine aminopeptidase and adipocyte-derived leucine aminopeptidase in human normal and malignant invasive trophoblastic cells. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.11.3 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14749039&form=6&db=m Insulin stimulates placental leucine aminopeptidase/oxytocinase/insulin-regulated membrane aminopeptidase expression in BeWo choriocarcinoma cells. ongoing research,unassigned 4,0 3.4.11.3 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15449704&form=6&db=m Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies. causal interaction,ongoing research,unassigned 2,1,0 3.4.11.3 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16364975&form=6&db=m Ikaros is expressed in human extravillous trophoblasts and involved in their migration and invasion. causal interaction,ongoing research,unassigned 1,1,0 3.4.11.3 Coinfection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9078465&form=6&db=m Expression and processing of the human immunodeficiency virus type 1 envelope glycoprotein. causal interaction,therapeutic application,unassigned 3,2,0 3.4.11.3 Coinfection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10710211&form=6&db=m Production and characterization of simian--human immunodeficiency virus-like particles. therapeutic application,unassigned 2,0 3.4.11.3 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7930718&form=6&db=m Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 2,3,0 3.4.11.3 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8245523&form=6&db=m Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,2,0 3.4.11.3 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9491504&form=6&db=m Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. therapeutic application,unassigned 4,0 3.4.11.3 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21544164&form=6&db=m HIV-1 envelope accessible surface and polarity: clade, blood, and brain. unassigned - 3.4.11.3 Cystadenoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15907336&form=6&db=m Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 3.4.11.3 Cystadenoma, Mucinous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15907336&form=6&db=m Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 3.4.11.3 cystinyl aminopeptidase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21895534&form=6&db=m Insulin-Regulated Aminopeptidase Deficiency Provides Protection against Ischemic Stroke in Mice. causal interaction,therapeutic application,unassigned 4,2,0 3.4.11.3 cystinyl aminopeptidase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33252660&form=6&db=m Insulin-regulated aminopeptidase deficiency impairs cardiovascular adaptations and placental development during pregnancy. causal interaction,therapeutic application,unassigned 4,1,0 3.4.11.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12430716&form=6&db=m HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia. ongoing research,unassigned 3,0 3.4.11.3 Dengue http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11747468&form=6&db=m Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIV. ongoing research,therapeutic application,unassigned 2,1,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3408061&form=6&db=m Vasopressinase and diabetes insipidus of pregnancy. diagnostic usage,unassigned 1,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3561459&form=6&db=m Diabetes insipidus in pregnancy associated with abnormally high circulating vasopressinase activity. causal interaction,diagnostic usage,unassigned 3,2,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7781620&form=6&db=m Pituitary disorders during pregnancy. causal interaction,unassigned 2,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7889632&form=6&db=m Loss of biological activity of arginine vasopressin during its degradation by vasopressinase from pregnancy serum. causal interaction,unassigned 4,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8228021&form=6&db=m [Diabetes insipidus and postpartum anterior hypophyseal insufficiency] causal interaction,therapeutic application,unassigned 1,1,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8334746&form=6&db=m Pathophysiology of transient cranial diabetes insipidus during pregnancy. diagnostic usage,ongoing research,unassigned 2,2,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8476482&form=6&db=m Vasopressinase-altered vasopressin elevates arterial pressure in anesthetized rats. unassigned - 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9201003&form=6&db=m The management of diabetes insipidus in adults. causal interaction,therapeutic application,unassigned 1,2,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9767808&form=6&db=m [Diabetes insipidus with a hypothalamo-hypophyseal morphologic anomaly during a pregnancy] causal interaction,unassigned 3,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9880116&form=6&db=m Pituitary diseases in pregnancy. causal interaction,unassigned 4,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15863571&form=6&db=m Diabetes insipidus in the third trimester of pregnancy. causal interaction,therapeutic application,unassigned 3,3,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17100823&form=6&db=m Transient postpartum diabetes insipidus associated with HELLP syndrome. causal interaction,unassigned 4,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19454377&form=6&db=m Diabetes insipidus in pregnancy: etiology, evaluation, and management. causal interaction,unassigned 4,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19959721&form=6&db=m Systemic arterial vasodilation, vasopressin, and vasopressinase in pregnancy. causal interaction,therapeutic application,unassigned 3,3,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20500966&form=6&db=m Gestational diabetes insipidus: a review of an underdiagnosed condition. ongoing research,therapeutic application,unassigned 3,2,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20664450&form=6&db=m Severe hydramnios and preterm delivery in association with transient maternal diabetes insipidus. causal interaction,unassigned 4,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20953066&form=6&db=m Recurrent pregnancy-induced diabetes insipidus in a woman with hemochromatosis. causal interaction,unassigned 4,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22967849&form=6&db=m Clinical Practice Guideline for Hypotalamic-Pituitary Disturbances in Pregnancy and the Postpartum Period. causal interaction,unassigned 3,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23393172&form=6&db=m Acute diabetes insipidus mediated by vasopressinase after placental abruption. causal interaction,unassigned 3,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27579058&form=6&db=m Diabetes insipidus in pregnancy. causal interaction,unassigned 2,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28420857&form=6&db=m Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy. therapeutic application,unassigned 1,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29378555&form=6&db=m The clinical course and pathophysiological investigation of adolescent gestational diabetes insipidus: a case report. causal interaction,unassigned 3,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29463074&form=6&db=m Diabetes insipidus in pregnancy: how to advice the patient? unassigned - 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29850023&form=6&db=m Transient diabetes insipidus in a post-partum woman with pre-eclampsia associated with residual placental vasopressinase activity. causal interaction,unassigned 3,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31345525&form=6&db=m Other Pituitary Conditions and Pregnancy. causal interaction,unassigned 4,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32138946&form=6&db=m Vasopressin inactivation: Role of insulin-regulated aminopeptidase. causal interaction,unassigned 3,0 3.4.11.3 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33713498&form=6&db=m Diagnosis and management of diabetes insipidus for the internist: an update. unassigned - 3.4.11.3 Diabetes Insipidus, Nephrogenic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9201003&form=6&db=m The management of diabetes insipidus in adults. causal interaction,therapeutic application,unassigned 1,2,0 3.4.11.3 Diabetes Insipidus, Nephrogenic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29463074&form=6&db=m Diabetes insipidus in pregnancy: how to advice the patient? unassigned - 3.4.11.3 Diabetes Insipidus, Nephrogenic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33713498&form=6&db=m Diagnosis and management of diabetes insipidus for the internist: an update. unassigned - 3.4.11.3 Diabetes Insipidus, Neurogenic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9201003&form=6&db=m The management of diabetes insipidus in adults. causal interaction,therapeutic application,unassigned 1,2,0 3.4.11.3 Diabetes Insipidus, Neurogenic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33713498&form=6&db=m Diagnosis and management of diabetes insipidus for the internist: an update. unassigned - 3.4.11.3 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11701721&form=6&db=m Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking. ongoing research,therapeutic application,unassigned 2,1,0 3.4.11.3 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34103176&form=6&db=m Circulating IRAPe, Irisin, and IL-34 in Relation to Insulin Resistance in Patients With Type 2 Diabetes. ongoing research,unassigned 4,0 3.4.11.3 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11701721&form=6&db=m Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking. ongoing research,therapeutic application,unassigned 2,1,0 3.4.11.3 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34103176&form=6&db=m Circulating IRAPe, Irisin, and IL-34 in Relation to Insulin Resistance in Patients With Type 2 Diabetes. ongoing research,unassigned 4,0 3.4.11.3 Diabetes, Gestational http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7889632&form=6&db=m Loss of biological activity of arginine vasopressin during its degradation by vasopressinase from pregnancy serum. causal interaction,unassigned 4,0 3.4.11.3 Diabetes, Gestational http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27609741&form=6&db=m Associations between serum placental leucine aminopeptidase and pregnancy outcomes. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,3,0 3.4.11.3 Diabetes, Gestational http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29378555&form=6&db=m The clinical course and pathophysiological investigation of adolescent gestational diabetes insipidus: a case report. causal interaction,unassigned 3,0 3.4.11.3 Diabetes, Gestational http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29463074&form=6&db=m Diabetes insipidus in pregnancy: how to advice the patient? unassigned - 3.4.11.3 Diabetes, Gestational http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32138946&form=6&db=m Vasopressin inactivation: Role of insulin-regulated aminopeptidase. causal interaction,unassigned 3,0 3.4.11.3 Diabetes, Gestational http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33713498&form=6&db=m Diagnosis and management of diabetes insipidus for the internist: an update. unassigned - 3.4.11.3 Diphtheria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1979339&form=6&db=m Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. ongoing research,unassigned 3,0 3.4.11.3 Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33762660&form=6&db=m Genetic association of ERAP1 and ERAP2 with eclampsia and preeclampsia in northeastern Brazilian women. causal interaction,unassigned 3,0 3.4.11.3 Encephalitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21544164&form=6&db=m HIV-1 envelope accessible surface and polarity: clade, blood, and brain. unassigned - 3.4.11.3 Endometrial Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=924762&form=6&db=m Serum cystine aminopeptidase and leucine aminopeptidase activity in women with benign and malignant uterine and ovarian tumors. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 3.4.11.3 Endometrial Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15218296&form=6&db=m Expression of placental leucine aminopeptidase is associated with a poor outcome in endometrial endometrioid adenocarcinoma. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,1 3.4.11.3 Endometrial Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15449704&form=6&db=m Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies. causal interaction,ongoing research,unassigned 2,1,0 3.4.11.3 Endometrial Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15491750&form=6&db=m Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,3 3.4.11.3 Endometrial Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16187279&form=6&db=m A novel role for placental leucine aminopeptidase (P-LAP) as a determinant of chemoresistance in endometrial carcinoma cells. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,3,1 3.4.11.3 Endometrial Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17233921&form=6&db=m P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,4,4 3.4.11.3 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23931276&form=6&db=m Circulating Aminopeptidase Activities in Men and Women with Essential Hypertension. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,1 3.4.11.3 Fatty Liver http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18825149&form=6&db=m Gestational diabetes insipidus and intrauterine fetal death of monochorionic twins. causal interaction,diagnostic usage,unassigned 1,1,0 3.4.11.3 Fatty Liver http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20953066&form=6&db=m Recurrent pregnancy-induced diabetes insipidus in a woman with hemochromatosis. causal interaction,unassigned 4,0 3.4.11.3 Fatty Liver http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26524979&form=6&db=m Transient diabetes insipidus in pregnancy. causal interaction,diagnostic usage,unassigned 4,1,0 3.4.11.3 Fetal Death http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14137906&form=6&db=m [DETERMINATION OF SERUM OXYTOCINASE IN PLACENTAL INSUFFICIENCY AND FETAL DEATH "IN UTERO".] diagnostic usage,ongoing research,unassigned 2,1,0 3.4.11.3 Fetal Death http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27609741&form=6&db=m Associations between serum placental leucine aminopeptidase and pregnancy outcomes. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,3,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=665162&form=6&db=m The value of serum cystine aminopeptidase (CAP), human chorionic somato-mammotrophin (HCS), and urinary oestrogen assays for detecting intrauterine growth retardation. diagnostic usage,unassigned 4,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=920768&form=6&db=m Oxytocinase and human placental lactogen for the prediction of intrauterine growth retardation. diagnostic usage,ongoing research,unassigned 3,3,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1212272&form=6&db=m [Serial determinations of serum oxytocinase and ultrasonic biparietal cephalometry in normal and high-risk pregnancies] causal interaction,diagnostic usage,unassigned 1,3,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3493952&form=6&db=m [Placental oxytocinase and alkaline phosphatase activities and the SP1-glycoprotein level in pregnancy complicated by intrauterine fetal growth retardation] causal interaction,unassigned 2,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4720524&form=6&db=m Diagnosis of intrauterine fetal growth retardation by serial serum oxytocinase, urinary oestrogen and serum heat stable alkaline phosphatase (HSAP) estimations in uncomplicated and hypertensive pregnancies. diagnostic usage,unassigned 4,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6158396&form=6&db=m Neurology and behaviour of growth-retarded neonates. Relation to biochemical placental function tests in late pregnancy. diagnostic usage,ongoing research,unassigned 2,2,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6158397&form=6&db=m An 18-month follow-up study of growth-retarded neonates. Relation to biochemical tests of placental function in late pregnancy and neurobehavioural condition in the newborn period. diagnostic usage,ongoing research,unassigned 2,1,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6578781&form=6&db=m Cystyl aminopeptidase in maternal serum for the antenatal recognition of fetal growth retardation. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6880465&form=6&db=m [Serum HPL, total estrogen excretion and serum oxytocinase in intrauterine retardation. Results of 3 evaluation procedures] diagnostic usage,ongoing research,unassigned 2,3,0 3.4.11.3 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7060818&form=6&db=m The use of human placental lactogen, oxytocinase and estriol in twin pregnancies with intrauterine growth retardation. unassigned - 3.4.11.3 Fibromyalgia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31131634&form=6&db=m Altered Serum Oxytocinase and Enkephalin-Degrading Aminopeptidase Activities in Patients With Fibromyalgia. causal interaction,diagnostic usage,unassigned 1,4,0 3.4.11.3 Fibromyalgia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33323834&form=6&db=m Associations Among Nitric Oxide and Enkephalinases With Fibromyalgia Symptoms. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,1 3.4.11.3 Glomerulosclerosis, Focal Segmental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7495302&form=6&db=m HIV-1 gp160 protein-macrophage interactions modulate mesangial cell proliferation and matrix synthesis. ongoing research,unassigned 3,0 3.4.11.3 Goiter http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5755007&form=6&db=m Blood levels of cystine aminopeptidase (oxytocinase) in patients with toxic and simple goiter. diagnostic usage,ongoing research,unassigned 2,1,0 3.4.11.3 Hearing Loss http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32032300&form=6&db=m Inter-rater Reliability and Validity of the Arabic Version of Categories of Auditory Performance-II (CAP-II) Among Children With Cochlear Implant. unassigned - 3.4.11.3 Hearing Loss http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33894523&form=6&db=m A normative study of auditory perception in Mandarin-speaking children with categories of auditory Performance-II. unassigned - 3.4.11.3 HELLP Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12122912&form=6&db=m Transient postpartum diabetes insipidus in twin pregnancy associated with HELLP syndrome. causal interaction,unassigned 3,0 3.4.11.3 HELLP Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17100823&form=6&db=m Transient postpartum diabetes insipidus associated with HELLP syndrome. causal interaction,unassigned 4,0 3.4.11.3 HELLP Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18825149&form=6&db=m Gestational diabetes insipidus and intrauterine fetal death of monochorionic twins. causal interaction,diagnostic usage,unassigned 1,1,0 3.4.11.3 HELLP Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20953066&form=6&db=m Recurrent pregnancy-induced diabetes insipidus in a woman with hemochromatosis. causal interaction,unassigned 4,0 3.4.11.3 HELLP Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26524979&form=6&db=m Transient diabetes insipidus in pregnancy. causal interaction,diagnostic usage,unassigned 4,1,0 3.4.11.3 HELLP Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33762660&form=6&db=m Genetic association of ERAP1 and ERAP2 with eclampsia and preeclampsia in northeastern Brazilian women. causal interaction,unassigned 3,0 3.4.11.3 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1845126&form=6&db=m Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees. ongoing research,unassigned 4,0 3.4.11.3 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5802127&form=6&db=m [Leucine aminopeptidase and cystinyl aminopeptidase activity of serum during the course of viral hepatitis, with reference to the effect of cortico therapy] causal interaction,diagnostic usage,unassigned 2,1,0 3.4.11.3 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26524979&form=6&db=m Transient diabetes insipidus in pregnancy. causal interaction,diagnostic usage,unassigned 4,1,0 3.4.11.3 Hepatitis B http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1360665&form=6&db=m Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine. ongoing research,therapeutic application,unassigned 2,1,0 3.4.11.3 Hepatitis B http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1613672&form=6&db=m B-cell activation and differentiation by HIV-1 antigens among volunteers vaccinated with VaxSyn HIV-1. causal interaction,ongoing research,therapeutic application,unassigned 1,4,2,0 3.4.11.3 Hepatitis B http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7483809&form=6&db=m Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. therapeutic application,unassigned 2,0 3.4.11.3 Hepatitis B http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10799863&form=6&db=m Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation. unassigned - 3.4.11.3 Herpes Simplex http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29093081&form=6&db=m Analysis of Select Herpes Simplex Virus 1 (HSV-1) Proteins for Restriction of Human Immunodeficiency Virus Type 1 (HIV-1): HSV-1 gM Protein Potently Restricts HIV-1 by Preventing Intracellular Transport and Processing of Env gp160. diagnostic usage,ongoing research,unassigned 3,3,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1433512&form=6&db=m Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. ongoing research,unassigned 2,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1548763&form=6&db=m Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum. causal interaction,unassigned 2,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1674589&form=6&db=m A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. causal interaction,ongoing research,therapeutic application,unassigned 4,4,4,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2884379&form=6&db=m Antibody response in primary human immunodeficiency virus infection. diagnostic usage,ongoing research,unassigned 3,3,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7621578&form=6&db=m Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS. diagnostic usage,ongoing research,unassigned 3,1,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7998425&form=6&db=m HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. ongoing research,therapeutic application,unassigned 1,2,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8811049&form=6&db=m HIV-1 gp160 induces transforming growth factor-beta production in human PBMC. causal interaction,therapeutic application,unassigned 4,3,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9064008&form=6&db=m Concomitant human immunodeficiency virus infection and syphilitic meningitis. diagnostic usage,therapeutic application,unassigned 1,2,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10990166&form=6&db=m Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working Group. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16318372&form=6&db=m [A case of primary HIV infection presenting as meningoencephalitis] diagnostic usage,unassigned 3,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17154036&form=6&db=m [A case of primary HIV infection presenting as mononeuritis multiplex] diagnostic usage,unassigned 3,0 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22243136&form=6&db=m Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 3.4.11.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30975069&form=6&db=m Unsupervised PrEP in routine practice: a new challenge? diagnostic usage,unassigned 2,0 3.4.11.3 HIV Seropositivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12134228&form=6&db=m Detection of antibodies to human immunodeficiency virus (HIV) that recognize conformational epitopes of glycoproteins 160 and 41 often allows for early diagnosis of HIV infection. diagnostic usage,unassigned 4,0 3.4.11.3 Hydatidiform Mole http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12361682&form=6&db=m Differential distribution of placental leucine aminopeptidase/oxytocinase and aminopeptidase A in human trophoblasts of normal placenta and complete hydatidiform mole. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Hyperalgesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23142109&form=6&db=m A possible correlation between oxytocin-induced and angiotensin IV-induced anti-hyperalgesia at the spinal level in rats. causal interaction,therapeutic application,unassigned 1,4,0 3.4.11.3 Hyperinsulinism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33176650&form=6&db=m Putative Involvement of Endocrine Disruptors in the Alzheimer's disease Via the Insulin-Regulated Aminopeptidase / GLUT4 Pathway. unassigned - 3.4.11.3 Hypernatremia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24555139&form=6&db=m Gestational Diabetes Insipidus Associated with HELLP Syndrome: A Case Report. unassigned - 3.4.11.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7930718&form=6&db=m Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 2,3,0 3.4.11.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8245523&form=6&db=m Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,2,0 3.4.11.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9144368&form=6&db=m Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group. ongoing research,therapeutic application,unassigned 3,3,0 3.4.11.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9491504&form=6&db=m Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. therapeutic application,unassigned 4,0 3.4.11.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19249316&form=6&db=m Oxytocin hypersensitivity in pregnant P-LAP deficient mice. causal interaction,ongoing research,unassigned 2,2,0 3.4.11.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21544164&form=6&db=m HIV-1 envelope accessible surface and polarity: clade, blood, and brain. unassigned - 3.4.11.3 Hypersensitivity, Delayed http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3162762&form=6&db=m A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=920768&form=6&db=m Oxytocinase and human placental lactogen for the prediction of intrauterine growth retardation. diagnostic usage,ongoing research,unassigned 3,3,0 3.4.11.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8235062&form=6&db=m Plasma angiotensin I concentration and serum placental leucine aminopeptidase (P-LAP) activities in puerperal hypertension. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,1,0 3.4.11.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11561217&form=6&db=m Effect of valsartan on angiotensin II- and vasopressin-degrading activities in the kidney of normotensive and hypertensive rats. therapeutic application,unassigned 4,0 3.4.11.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33762660&form=6&db=m Genetic association of ERAP1 and ERAP2 with eclampsia and preeclampsia in northeastern Brazilian women. causal interaction,unassigned 3,0 3.4.11.3 Hypertension, Pregnancy-Induced http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3186091&form=6&db=m Change in plasma cystyl aminopeptidase (oxytocinase) between 30-34 weeks' gestation as a predictor of pregnancy-induced hypertension. diagnostic usage,unassigned 2,0 3.4.11.3 Hypertension, Pregnancy-Induced http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21043609&form=6&db=m Serum Vasopressinase and Platelet Responses to Arginine Vasopressin in Normal Pregnancy, Pregnancy-induced Hypertension and Pre-eclampsia. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.4.11.3 Hyperthyroidism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29920473&form=6&db=m Cystinyl and pyroglutamyl-beta-naphthylamide hydrolyzing activities are modified coordinately between hypothalamus, liver and plasma depending on the thyroid status of adult male rats. diagnostic usage,unassigned 1,0 3.4.11.3 Hyperthyroidism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30555423&form=6&db=m Thyroid Disorders Change the Pattern of Response of Angiotensinase Activities in the Hypothalamus-Pituitary-Adrenal Axis of Male Rats. unassigned - 3.4.11.3 Hypothalamic Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2698144&form=6&db=m Volume homeostasis and osmoregulation in human pregnancy. unassigned - 3.4.11.3 Hypothyroidism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29920473&form=6&db=m Cystinyl and pyroglutamyl-beta-naphthylamide hydrolyzing activities are modified coordinately between hypothalamus, liver and plasma depending on the thyroid status of adult male rats. diagnostic usage,unassigned 1,0 3.4.11.3 Immune System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33101040&form=6&db=m IRAP Inhibitors: M1-Aminopeptidase Family Inspiration. causal interaction,therapeutic application,unassigned 3,4,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1353102&form=6&db=m Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1538159&form=6&db=m Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) type 1 infection mediated by Fc receptors using sera from recipients of a recombinant gp160 experimental HIV-1 vaccine. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1727607&form=6&db=m Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells. ongoing research,unassigned 3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1742074&form=6&db=m Cross-neutralizing antibodies in rabbits immunized with HIV-1 gp160 purified from simian cells infected with a recombinant vaccinia virus. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1742945&form=6&db=m Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. ongoing research,therapeutic application,unassigned 1,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1942241&form=6&db=m Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. causal interaction,ongoing research,unassigned 1,4,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2190095&form=6&db=m Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. ongoing research,therapeutic application,unassigned 1,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2265028&form=6&db=m Interactive laser cytometric analysis of retroviral protein expression in HIV-infected lymphocytic cell lines. diagnostic usage,ongoing research,unassigned 1,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2523711&form=6&db=m HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors. ongoing research,unassigned 3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2536094&form=6&db=m Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera. ongoing research,therapeutic application,unassigned 3,3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2695538&form=6&db=m Flow cytometric assays for monitoring production of recombinant HIV-1 gp160 in insect cells infected with a baculovirus expression vector. ongoing research,unassigned 2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3050377&form=6&db=m Replication of human immunodeficiency virus in two T-cell lines and their application as antigens for immunofluorescence. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3346572&form=6&db=m Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. diagnostic usage,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7598771&form=6&db=m A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7602128&form=6&db=m Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7666524&form=6&db=m Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. diagnostic usage,ongoing research,unassigned 3,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7688766&form=6&db=m Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7693862&form=6&db=m Infection of human monocyte-derived macrophages by human immunodeficiency virus mediated by cell-to-cell transmission. unassigned - 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7844384&form=6&db=m Immunization of chimpanzees with recombinant gp160, but not infection with human immunodeficiency virus type 1, induces envelope-specific Th1 memory cells. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7893438&form=6&db=m Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques. therapeutic application,unassigned 3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964606&form=6&db=m Extensive C-terminal deletion in human immunodeficiency virus type 1 Env glycoprotein arising after long-term culture of chronically infected cells. diagnostic usage,ongoing research,unassigned 1,3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8198872&form=6&db=m Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. ongoing research,therapeutic application,unassigned 1,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8207641&form=6&db=m Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr. therapeutic application,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8235446&form=6&db=m Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8245523&form=6&db=m Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8346417&form=6&db=m Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. causal interaction,therapeutic application,unassigned 2,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8409933&form=6&db=m Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal. causal interaction,therapeutic application,unassigned 1,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8411113&form=6&db=m Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160. ongoing research,therapeutic application,unassigned 1,3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8460155&form=6&db=m Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8483471&form=6&db=m [Pathological cleavage of human immunodeficiency virus gp160 protein in infected cells as a probable factor for infection becoming chronic] diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8764041&form=6&db=m Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8787894&form=6&db=m Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor. ongoing research,unassigned 2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8892923&form=6&db=m A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells. diagnostic usage,therapeutic application,unassigned 3,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8892959&form=6&db=m Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain. ongoing research,therapeutic application,unassigned 1,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8926281&form=6&db=m Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection. causal interaction,diagnostic usage,unassigned 2,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8941318&form=6&db=m Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35). therapeutic application,unassigned 4,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9232434&form=6&db=m Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design. therapeutic application,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9271324&form=6&db=m Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". therapeutic application,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9419172&form=6&db=m Persistent infection by Helicobacter pylori down-modulates virus-specific CD8+ cytotoxic T cell response and prolongs viral infection. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9465081&form=6&db=m Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. ongoing research,therapeutic application,unassigned 3,4,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9469464&form=6&db=m HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9573257&form=6&db=m An evolutionarily conserved splice generates a secreted env-Bet fusion protein during human foamy virus infection. causal interaction,unassigned 2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9650619&form=6&db=m Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication. ongoing research,therapeutic application,unassigned 2,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9686639&form=6&db=m Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. causal interaction,therapeutic application,unassigned 3,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9878016&form=6&db=m Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10074165&form=6&db=m Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines. therapeutic application,unassigned 4,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10225274&form=6&db=m Processing and routage of HIV glycoproteins by furin to the cell surface. causal interaction,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10347985&form=6&db=m Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial. Nordic VAC-04 Study Group. ongoing research,therapeutic application,unassigned 2,4,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10357469&form=6&db=m Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage. ongoing research,therapeutic application,unassigned 3,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10482571&form=6&db=m Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques. causal interaction,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10489976&form=6&db=m Immunisation with gp160 in HIV-1 infection. causal interaction,therapeutic application,unassigned 2,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10489977&form=6&db=m Immunisation with gp160 in HIV-1 infection. causal interaction,therapeutic application,unassigned 2,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10706640&form=6&db=m Recombinant rabies virus as potential live-viral vaccines for HIV-1. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10710213&form=6&db=m Role of nitric oxide in the promoting effect of HIV type 1 infection and of gp120 envelope glycoprotein on interleukin 4-induced IgE production by normal human mononuclear cells. ongoing research,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10789510&form=6&db=m Inhibition of HIV-1 infection by an intramolecular antisense peptide to T20 in gp160. therapeutic application,unassigned 3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11062061&form=6&db=m Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication. causal interaction,ongoing research,therapeutic application,unassigned 1,3,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11180117&form=6&db=m Impaired development of HIV-1 gp160-specific CD8(+) cytotoxic T cells by a delayed switch from Th1 to Th2 cytokine phenotype in mice with Helicobacter pylori infection. unassigned - 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11836398&form=6&db=m Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy. ongoing research,therapeutic application,unassigned 3,3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12076047&form=6&db=m DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus. therapeutic application,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14694134&form=6&db=m Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15117456&form=6&db=m Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15295694&form=6&db=m Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. ongoing research,therapeutic application,unassigned 3,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15371436&form=6&db=m Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16051804&form=6&db=m Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. diagnostic usage,therapeutic application,unassigned 3,2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16081772&form=6&db=m Cutting edge: a single MHC class Ia is sufficient for CD8 memory T cell differentiation. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16834457&form=6&db=m Insensitivity of Paediatric HIV-1 Subtype C Viruses to Broadly Neutralising Monoclonal Antibodies Raised against Subtype B. ongoing research,unassigned 3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16971434&form=6&db=m Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. ongoing research,unassigned 3,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17210123&form=6&db=m Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments. therapeutic application,unassigned 2,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18455841&form=6&db=m Long-term increase of CD4(+) central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization. ongoing research,therapeutic application,unassigned 2,4,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18524815&form=6&db=m Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. therapeutic application,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23740975&form=6&db=m Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120. therapeutic application,unassigned 1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24006141&form=6&db=m Acute HIV-1 seroconversion with an unusual plasma biomarker profile. causal interaction,therapeutic application,unassigned 3,1,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25927639&form=6&db=m Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,4,0 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27117672&form=6&db=m The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection. unassigned - 3.4.11.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29870744&form=6&db=m Bioengineered intravaginal isolate of Lactobacillus plantarum expresses algal lectin scytovirin demonstrating anti-HIV-1 activity. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,2,0 3.4.11.3 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8846927&form=6&db=m [Results of fetal monitoring in pregnancy with enzymatic and neuroendocrinologic risk factors] causal interaction,therapeutic application,unassigned 1,4,0 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1845391&form=6&db=m Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2184369&form=6&db=m Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2524668&form=6&db=m Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7906300&form=6&db=m Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160. therapeutic application,unassigned 1,0 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8661397&form=6&db=m Membrane anchorage of gp160 is necessary and sufficient to prevent CD4 transport to the cell surface. therapeutic application,unassigned 2,0 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10486104&form=6&db=m Recombinant vaccinia viruses expressing an immunodominant epitope of HIV-1 envelope protein within an influenza hemagglutinin cassette predominantly prime epitope-specific CD8(+) CTL. ongoing research,unassigned 4,0 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11118074&form=6&db=m T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy. diagnostic usage,therapeutic application,unassigned 1,1,0 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11426696&form=6&db=m Virus membrane fusion proteins: biological machines that undergo a metamorphosis. unassigned - 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14694134&form=6&db=m Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15068858&form=6&db=m Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. ongoing research,unassigned 4,0 3.4.11.3 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15928022&form=6&db=m Initial entry of IRAP into the insulin-responsive storage compartment occurs prior to basal or insulin-stimulated plasma membrane recycling. unassigned - 3.4.11.3 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34103176&form=6&db=m Circulating IRAPe, Irisin, and IL-34 in Relation to Insulin Resistance in Patients With Type 2 Diabetes. ongoing research,unassigned 4,0 3.4.11.3 Ischemic Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21895534&form=6&db=m Insulin-Regulated Aminopeptidase Deficiency Provides Protection against Ischemic Stroke in Mice. causal interaction,therapeutic application,unassigned 4,2,0 3.4.11.3 Kidney Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6946460&form=6&db=m Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins. diagnostic usage,ongoing research,unassigned 3,3,0 3.4.11.3 Leishmaniasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33775769&form=6&db=m Expression in Escherichia coli, purification and kinetic characterization of LAPLm, a Leishmania major M17-aminopeptidase. causal interaction,therapeutic application,unassigned 3,4,0 3.4.11.3 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2529399&form=6&db=m In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates. diagnostic usage,ongoing research,unassigned 2,3,0 3.4.11.3 Leukemia, T-Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8419650&form=6&db=m Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18825149&form=6&db=m Gestational diabetes insipidus and intrauterine fetal death of monochorionic twins. causal interaction,diagnostic usage,unassigned 1,1,0 3.4.11.3 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20953066&form=6&db=m Recurrent pregnancy-induced diabetes insipidus in a woman with hemochromatosis. causal interaction,unassigned 4,0 3.4.11.3 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25832854&form=6&db=m Acute presentation of gestational diabetes insipidus with pre-eclampsia complicated by cerebral vasoconstriction: A case report and review of the published work. causal interaction,unassigned 3,0 3.4.11.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2790790&form=6&db=m Correspondence re: Yasuyuki Sugiyama et al., Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibody. ongoing research,unassigned 3,0 3.4.11.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3359438&form=6&db=m Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibody. causal interaction,ongoing research,therapeutic application,unassigned 3,4,4,0 3.4.11.3 Mastocytoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25980430&form=6&db=m The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation. diagnostic usage,therapeutic application,unassigned 2,2,0 3.4.11.3 Measles http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7906300&form=6&db=m Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160. therapeutic application,unassigned 1,0 3.4.11.3 Measles http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21890164&form=6&db=m A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells. ongoing research,unassigned 1,0 3.4.11.3 Melanoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32622867&form=6&db=m From putative brain tumor marker to high cognitive abilities: Emerging roles of a disintegrin and metalloprotease (ADAM) 12 in the brain. causal interaction,diagnostic usage,unassigned 4,3,0 3.4.11.3 Memory Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10234025&form=6&db=m Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. therapeutic application,unassigned 1,0 3.4.11.3 Memory Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11730987&form=6&db=m A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits. therapeutic application,unassigned 2,0 3.4.11.3 Memory Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19126664&form=6&db=m The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease. causal interaction,therapeutic application,unassigned 4,4,0 3.4.11.3 Memory Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20628006&form=6&db=m Phenylalanine-544 plays a key role in substrate and inhibitor binding by providing a hydrophobic packing point at the active site of insulin-regulated aminopeptidase. causal interaction,therapeutic application,unassigned 3,4,0 3.4.11.3 Memory Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21348480&form=6&db=m Regulation of insulin-regulated membrane aminopeptidase activity by its C-terminal domain. causal interaction,therapeutic application,unassigned 3,4,0 3.4.11.3 Memory Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27713012&form=6&db=m Forebrain neurone-specific deletion of insulin-regulated aminopeptidase causes age related deficits in memory. therapeutic application,unassigned 3,0 3.4.11.3 Metabolic Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32138946&form=6&db=m Vasopressin inactivation: Role of insulin-regulated aminopeptidase. causal interaction,unassigned 3,0 3.4.11.3 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2582069&form=6&db=m [The significance of serum leucine aminopeptidase (P-LAP) determination in the gynecological malignancies] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 3.4.11.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31251594&form=6&db=m Novel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding Interactions. causal interaction,unassigned 3,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=924762&form=6&db=m Serum cystine aminopeptidase and leucine aminopeptidase activity in women with benign and malignant uterine and ovarian tumors. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1993354&form=6&db=m Effect of a recombinant HIV gp160 vaccine on monokine production. ongoing research,therapeutic application,unassigned 2,4,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2420442&form=6&db=m Trophoblastic proteins as tumor markers in nonseminomatous germ cell tumors. diagnostic usage,ongoing research,unassigned 4,2,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2529399&form=6&db=m In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates. diagnostic usage,ongoing research,unassigned 2,3,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2582069&form=6&db=m [The significance of serum leucine aminopeptidase (P-LAP) determination in the gynecological malignancies] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2659165&form=6&db=m Cell surface glycoprotein associated with human lung tumors that is similar to but distinct from the epidermal growth factor receptor. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,3,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3359438&form=6&db=m Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibody. causal interaction,ongoing research,therapeutic application,unassigned 3,4,4,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3484527&form=6&db=m Morphology surface of a mouse plasmacytoma (LPC-1) showing cyclic resistance to immune lysis. unassigned - 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4167682&form=6&db=m [Leucyl-aminopeptidase, thioacetic acid esterase and E 600-resistant esterase in cervix uteri cancer] diagnostic usage,unassigned 1,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6101623&form=6&db=m Expression of oncodevelopmental gene products by human tumor cells in culture. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7477703&form=6&db=m [A case of pineoblastoma successfully treated with surgery, combined chemotherapy of cisplatin and etoposide, and radiotherapy] diagnostic usage,unassigned 4,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7706435&form=6&db=m The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells. causal interaction,ongoing research,therapeutic application,unassigned 2,3,1,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9664120&form=6&db=m Aminopeptidase A expression and enzymatic activity in primary human renal cancers. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10085412&form=6&db=m Enhanced HIV-1 envelope-tumor protection by a recombinant vaccinia virus expressing anchored HIV-1 gp120 lacking gp41. causal interaction,ongoing research,unassigned 3,4,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10384115&form=6&db=m A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL. diagnostic usage,ongoing research,unassigned 3,3,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12792802&form=6&db=m The transmembrane domain of vesicular stomatitis virus glycoprotein suffices to anchor HIV-1 envelope gp120 expressed by a recombinant vaccinia virus. ongoing research,therapeutic application,unassigned 1,1,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14691298&form=6&db=m Expression of placental leucine aminopeptidase and adipocyte-derived leucine aminopeptidase in human normal and malignant invasive trophoblastic cells. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15060433&form=6&db=m Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals. unassigned - 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15234194&form=6&db=m Serum oxytocinase activity is related to tumor growth parameters in N-methyl nitrosourea induced rat breast cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,3,2 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15449704&form=6&db=m Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies. causal interaction,ongoing research,unassigned 2,1,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15907336&form=6&db=m Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16619500&form=6&db=m Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,3,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17373876&form=6&db=m Essential role of placental leucine aminopeptidase in gynecologic malignancy. causal interaction,ongoing research,unassigned 4,1,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18275097&form=6&db=m Effects of ligands or substrate of insulin-regulated aminopeptidase (IRAP) on trophoblast invasion. causal interaction,ongoing research,unassigned 3,3,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23816624&form=6&db=m Antiproliferative effects of palladium(II) complexes of 5-nitrosopyrimidines and interactions with the proteolytic regulatory enzymes of the renin-angiotensin system in tumoral brain cells. ongoing research,unassigned 3,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28441375&form=6&db=m Primary Adrenal Angiosarcoma: A Rare and Potentially Misdiagnosed Tumor. diagnostic usage,unassigned 2,0 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30641691&form=6&db=m Comparative study to evaluate the effect of l-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patients. unassigned - 3.4.11.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31251594&form=6&db=m Novel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding Interactions. causal interaction,unassigned 3,0 3.4.11.3 Neoplasms, Germ Cell and Embryonal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2420442&form=6&db=m Trophoblastic proteins as tumor markers in nonseminomatous germ cell tumors. diagnostic usage,ongoing research,unassigned 4,2,0 3.4.11.3 Neuroblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30370863&form=6&db=m Differential Effects of Doxazosin on Renin-Angiotensin-System-Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells. causal interaction,ongoing research,unassigned 1,4,0 3.4.11.3 Newcastle Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24098600&form=6&db=m Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 Newcastle Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26199332&form=6&db=m Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges. ongoing research,therapeutic application,unassigned 1,1,0 3.4.11.3 Newcastle Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26581986&form=6&db=m Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins. therapeutic application,unassigned 2,0 3.4.11.3 Newcastle Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29895833&form=6&db=m Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus. ongoing research,therapeutic application,unassigned 1,2,0 3.4.11.3 Newcastle Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33315934&form=6&db=m Retraction: Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector. therapeutic application,unassigned 2,0 3.4.11.3 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24389591&form=6&db=m Hypooxytocinaemia in obese Zucker rats relates to oxytocin degradation in liver and adipose tissue. causal interaction,therapeutic application,unassigned 4,4,0 3.4.11.3 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25999180&form=6&db=m Insulin-regulated aminopeptidase in adipocyte is Cys-specific and affected by obesity. causal interaction,unassigned 3,0 3.4.11.3 Obstetric Labor, Premature http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=856913&form=6&db=m [Ethanol perfusions during threatened premature labor. Special study of oxytocinase activity] ongoing research,unassigned 3,0 3.4.11.3 Obstetric Labor, Premature http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4072476&form=6&db=m [Cystine aminopeptidase and oxytocin in the plasma of pregnant patients with premature labor] causal interaction,diagnostic usage,unassigned 3,2,0 3.4.11.3 Obstetric Labor, Premature http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11376666&form=6&db=m Maternal serum placental leucine aminopeptidase (P-LAP)/oxytocinase and preterm delivery. diagnostic usage,ongoing research,unassigned 4,3,0 3.4.11.3 Obstetric Labor, Premature http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21034747&form=6&db=m A new approach regarding the treatment of preeclampsia and preterm labor. therapeutic application,unassigned 3,0 3.4.11.3 Obstetric Labor, Premature http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23931642&form=6&db=m New insights into the role of aminopeptidases in the treatment for both preeclampsia and preterm labor. causal interaction,therapeutic application,unassigned 4,4,0 3.4.11.3 Obstetric Labor, Premature http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25658663&form=6&db=m New Insights into the Role of Sex Steroid Hormones in Pregnancy: Possible Therapeutic Approach by Sex Steroid Hormones for the Treatment of Both Preeclampsia and Preterm Labor. causal interaction,unassigned 3,0 3.4.11.3 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2582069&form=6&db=m [The significance of serum leucine aminopeptidase (P-LAP) determination in the gynecological malignancies] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 3.4.11.3 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7446622&form=6&db=m Early primary diagnosis of ovarian cancer and detection of recurrence by serum cystine aminopeptidase assay. diagnostic usage,ongoing research,unassigned 4,4,0 3.4.11.3 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15449704&form=6&db=m Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies. causal interaction,ongoing research,unassigned 2,1,0 3.4.11.3 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15907336&form=6&db=m Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 3.4.11.3 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34465271&form=6&db=m CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis. causal interaction,diagnostic usage,unassigned 3,1,0 3.4.11.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20576539&form=6&db=m Lateralized response of oxytocinase activity in the medial prefrontal cortex of a unilateral rat model of Parkinson's disease. ongoing research,unassigned 2,0 3.4.11.3 Persistent Infection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9573257&form=6&db=m An evolutionarily conserved splice generates a secreted env-Bet fusion protein during human foamy virus infection. causal interaction,unassigned 2,0 3.4.11.3 Placental Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6578781&form=6&db=m Cystyl aminopeptidase in maternal serum for the antenatal recognition of fetal growth retardation. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 3.4.11.3 Placental Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14137906&form=6&db=m [DETERMINATION OF SERUM OXYTOCINASE IN PLACENTAL INSUFFICIENCY AND FETAL DEATH "IN UTERO".] diagnostic usage,ongoing research,unassigned 2,1,0 3.4.11.3 Pneumonia, Pneumocystis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19522309&form=6&db=m [A case of HIV-1 infection that showed Western blot analysis for HIV-1 negative after antiretroviral therapy] therapeutic application,unassigned 1,0 3.4.11.3 Polyhydramnios http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20664450&form=6&db=m Severe hydramnios and preterm delivery in association with transient maternal diabetes insipidus. causal interaction,unassigned 4,0 3.4.11.3 Polyuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20664450&form=6&db=m Severe hydramnios and preterm delivery in association with transient maternal diabetes insipidus. causal interaction,unassigned 4,0 3.4.11.3 Polyuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28420857&form=6&db=m Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy. therapeutic application,unassigned 1,0 3.4.11.3 Polyuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32205050&form=6&db=m Gestational diabetes insipidus: Diagnosis and management. unassigned - 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2192237&form=6&db=m A proposed relationship between vasopressinase altered vasopressin and preeclampsia. causal interaction,unassigned 4,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4015192&form=6&db=m Plasma angiotensin I and serum placental leucine aminopeptidase (P-LAP) in pre-eclampsia. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,3 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5935239&form=6&db=m [Serum oxytocinase in prolonged pregnancy and pre-eclampsia] diagnostic usage,unassigned 2,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6520481&form=6&db=m [Estimation of placental leucine aminopeptidase (P-LAP) in pregnancy sera] diagnostic usage,ongoing research,unassigned 3,2,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6646013&form=6&db=m A hypothesis on the role of antidiuretic hormone in preeclampsia. causal interaction,unassigned 3,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7889632&form=6&db=m Loss of biological activity of arginine vasopressin during its degradation by vasopressinase from pregnancy serum. causal interaction,unassigned 4,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8235062&form=6&db=m Plasma angiotensin I concentration and serum placental leucine aminopeptidase (P-LAP) activities in puerperal hypertension. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,1,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8505009&form=6&db=m Decreased levels of amniotic fluid oxytocinase activity in preeclampsia. causal interaction,ongoing research,unassigned 1,1,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8783784&form=6&db=m Effects of placental proteases on maternal and fetal blood pressure in normal pregnancy and preeclampsia. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9767808&form=6&db=m [Diabetes insipidus with a hypothalamo-hypophyseal morphologic anomaly during a pregnancy] causal interaction,unassigned 3,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14227595&form=6&db=m PREECLAMPSIA ASSOCIATED WITH DECREASE IN SERUM OXYTOCINASE. causal interaction,diagnostic usage,unassigned 4,2,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15894523&form=6&db=m Gene regulation and physiological function of placental leucine aminopeptidase/oxytocinase during pregnancy. unassigned - 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20150869&form=6&db=m Alteration of circulating Placental Leucine Aminopeptidase (P-LAP) activity in preeclampsia. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,1 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21034747&form=6&db=m A new approach regarding the treatment of preeclampsia and preterm labor. therapeutic application,unassigned 3,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21043609&form=6&db=m Serum Vasopressinase and Platelet Responses to Arginine Vasopressin in Normal Pregnancy, Pregnancy-induced Hypertension and Pre-eclampsia. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23931642&form=6&db=m New insights into the role of aminopeptidases in the treatment for both preeclampsia and preterm labor. causal interaction,therapeutic application,unassigned 4,4,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25658663&form=6&db=m New Insights into the Role of Sex Steroid Hormones in Pregnancy: Possible Therapeutic Approach by Sex Steroid Hormones for the Treatment of Both Preeclampsia and Preterm Labor. causal interaction,unassigned 3,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26105274&form=6&db=m OS060. Exercise training promotes placental growth and development in an animal model of preeclampsia superimposed on chronic hypertension. causal interaction,ongoing research,unassigned 3,4,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29850023&form=6&db=m Transient diabetes insipidus in a post-partum woman with pre-eclampsia associated with residual placental vasopressinase activity. causal interaction,unassigned 3,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32138946&form=6&db=m Vasopressin inactivation: Role of insulin-regulated aminopeptidase. causal interaction,unassigned 3,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32619880&form=6&db=m The role of LNPEP and ANPEP gene polymorphisms in the pathogenesis of pre-eclampsia. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,4,1 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33252660&form=6&db=m Insulin-regulated aminopeptidase deficiency impairs cardiovascular adaptations and placental development during pregnancy. causal interaction,therapeutic application,unassigned 4,1,0 3.4.11.3 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33762660&form=6&db=m Genetic association of ERAP1 and ERAP2 with eclampsia and preeclampsia in northeastern Brazilian women. causal interaction,unassigned 3,0 3.4.11.3 Precursor Cell Lymphoblastic Leukemia-Lymphoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2529399&form=6&db=m In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates. diagnostic usage,ongoing research,unassigned 2,3,0 3.4.11.3 Pregnancy Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2562585&form=6&db=m [Oxytocinase in pregnancy complications] unassigned - 3.4.11.3 Pregnancy Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2617129&form=6&db=m [Oxytocinase activity in pregnancy complications] diagnostic usage,ongoing research,unassigned 2,2,0 3.4.11.3 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1304527&form=6&db=m [Placental lactogen level and activity of oxytocinase, beta-glucuronidase and thermostable alkaline phosphatase isoenzyme in blood serum of women with ectopic pregnancy] diagnostic usage,ongoing research,unassigned 4,1,0 3.4.11.3 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6217088&form=6&db=m Predictive value analysis of measurements of human chorionic gonadotropin, pregnancy specific beta 1-glycoprotein, placental lactogen, and cystine aminopeptidase for the diagnosis of ectopic pregnancy. diagnostic usage,ongoing research,unassigned 4,3,0 3.4.11.3 Pregnancy, High-Risk http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=266333&form=6&db=m Colpocytograms and maternal serum placental cystine aminopeptidase, tissue cystine aminopeptidase, alkaline phosphatase and heat stable alkaline phosphatase activity in monitoring the last four weeks before delivery in high-risk pregnancy. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.4.11.3 Pregnancy, High-Risk http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1011062&form=6&db=m Comparative prognostic value of serum placental and tissue oxytocinase, alkaline phosphatase and its heat-stable fraction in pregnancy at neuroendocrinological risk. therapeutic application,unassigned 1,0 3.4.11.3 Pregnancy, High-Risk http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1212272&form=6&db=m [Serial determinations of serum oxytocinase and ultrasonic biparietal cephalometry in normal and high-risk pregnancies] causal interaction,diagnostic usage,unassigned 1,3,0 3.4.11.3 Pregnancy, Prolonged http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23981&form=6&db=m [Activity of oxytocinase, leucine aminopeptidase and glutamyl-transferase in term pregnancy and prolonged pregnancy] unassigned - 3.4.11.3 Pregnancy, Prolonged http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5434485&form=6&db=m [The activity of serum oxytocinase in prolonged pregnancy] diagnostic usage,unassigned 4,0 3.4.11.3 Pregnancy, Prolonged http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5667746&form=6&db=m [The behavior of serum oxytocinase in cases of prolonged pregnancy] diagnostic usage,unassigned 4,0 3.4.11.3 Pregnancy, Prolonged http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5677852&form=6&db=m [The effect of estrogen administration on the level of serum oxytocinase in prolonged pregnancy] diagnostic usage,ongoing research,unassigned 2,2,0 3.4.11.3 Pregnancy, Prolonged http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5935239&form=6&db=m [Serum oxytocinase in prolonged pregnancy and pre-eclampsia] diagnostic usage,unassigned 2,0 3.4.11.3 Pregnancy, Prolonged http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6520481&form=6&db=m [Estimation of placental leucine aminopeptidase (P-LAP) in pregnancy sera] diagnostic usage,ongoing research,unassigned 3,2,0 3.4.11.3 Pregnancy, Prolonged http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7390243&form=6&db=m [Role of oxytocinase (CAP) in prolonged pregnancy] unassigned - 3.4.11.3 Pregnancy, Prolonged http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14196412&form=6&db=m PROLONGED PREGNANCY ASSOCIATED WITH INCREASE IN SERUM OXYTOCINASE. causal interaction,diagnostic usage,unassigned 4,2,0 3.4.11.3 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8280480&form=6&db=m Immunization with recombinant gp160 prolongs the survival of HIV-1 transgenic mice. diagnostic usage,ongoing research,therapeutic application,unassigned 2,3,1,0 3.4.11.3 Psoriasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23897274&form=6&db=m Identification of a Missense Variant in LNPEP that Confers Psoriasis Risk. causal interaction,unassigned 3,0 3.4.11.3 Rabies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3237686&form=6&db=m Improved antigenicity of the HIV env protein by cleavage site removal. ongoing research,unassigned 3,0 3.4.11.3 Rabies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11507217&form=6&db=m Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector. ongoing research,therapeutic application,unassigned 1,3,0 3.4.11.3 Rabies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11739668&form=6&db=m Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells. ongoing research,unassigned 2,0 3.4.11.3 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16771832&form=6&db=m Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats. ongoing research,therapeutic application,unassigned 3,1,0 3.4.11.3 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21612947&form=6&db=m Deletion of insulin-regulated aminopeptidase in mice decreases susceptibility to pentylenetetrazol-induced generalized seizures. ongoing research,unassigned 2,0 3.4.11.3 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26311777&form=6&db=m Trans-Modulation of the Somatostatin Type 2A Receptor Trafficking by Insulin-Regulated Aminopeptidase Decreases Limbic Seizures. unassigned - 3.4.11.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32138946&form=6&db=m Vasopressin inactivation: Role of insulin-regulated aminopeptidase. causal interaction,unassigned 3,0 3.4.11.3 Shock, Septic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11990905&form=6&db=m Depletion of neurohypophyseal content of vasopressin in septic shock. diagnostic usage,therapeutic application,unassigned 4,1,0 3.4.11.3 Shock, Septic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21330387&form=6&db=m Leucyl/cystinyl aminopeptidase (LNPEP) gene variants in septic shock. causal interaction,ongoing research,unassigned 3,1,0 3.4.11.3 Shock, Septic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27834335&form=6&db=m A PCR-RFLP method for detection of the LNPEP encoding human insulin-regulated aminopeptidase (IRAP) rs4869317 polymorphism. therapeutic application,unassigned 2,0 3.4.11.3 Smallpox http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1671940&form=6&db=m Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Stillbirth http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27859398&form=6&db=m Urinary sex steroid hormone and placental leucine aminopeptidase concentration differences between live births and stillbirth of Bornean orangutans (Pongo pygmaeus). therapeutic application,unassigned 1,0 3.4.11.3 Stomatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12792802&form=6&db=m The transmembrane domain of vesicular stomatitis virus glycoprotein suffices to anchor HIV-1 envelope gp120 expressed by a recombinant vaccinia virus. ongoing research,therapeutic application,unassigned 1,1,0 3.4.11.3 Tetanus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7906300&form=6&db=m Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160. therapeutic application,unassigned 1,0 3.4.11.3 Tetanus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8445264&form=6&db=m Use of particulate forms of protein antigens to increase the sensitivity of antigen-specific proliferation assays. ongoing research,unassigned 3,0 3.4.11.3 Tetanus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9158092&form=6&db=m Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Tetanus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12004273&form=6&db=m A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,1,0 3.4.11.3 Thrombosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18333378&form=6&db=m A clinical approach in regression of glomerulosclerosis. causal interaction,therapeutic application,unassigned 3,3,0 3.4.11.3 Thrombosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19745198&form=6&db=m Ablation of Angiotensin IV Receptor Attenuates Hypofibrinolysis via PAI-1 Downregulation and Reduces Occlusive Arterial Thrombosis. therapeutic application,unassigned 1,0 3.4.11.3 Thrombosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20975035&form=6&db=m Angiotensin II-Mediated Microvascular Thrombosis. causal interaction,ongoing research,therapeutic application,unassigned 3,2,3,0 3.4.11.3 Thrombosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32728402&form=6&db=m Current Trends on Glomerulosclerosis Regression. unassigned - 3.4.11.3 Toxemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2192237&form=6&db=m A proposed relationship between vasopressinase altered vasopressin and preeclampsia. causal interaction,unassigned 4,0 3.4.11.3 Toxoplasmosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32926129&form=6&db=m X-ray crystal structure and specificity of the Toxoplasma gondii ME49 TgAPN2. causal interaction,therapeutic application,unassigned 3,4,0 3.4.11.3 Trophoblastic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14691298&form=6&db=m Expression of placental leucine aminopeptidase and adipocyte-derived leucine aminopeptidase in human normal and malignant invasive trophoblastic cells. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.11.3 Trophoblastic Tumor, Placental Site http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14691298&form=6&db=m Expression of placental leucine aminopeptidase and adipocyte-derived leucine aminopeptidase in human normal and malignant invasive trophoblastic cells. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.4.11.3 Tuberculosis, Pulmonary http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19522309&form=6&db=m [A case of HIV-1 infection that showed Western blot analysis for HIV-1 negative after antiretroviral therapy] therapeutic application,unassigned 1,0 3.4.11.3 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15449704&form=6&db=m Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies. causal interaction,ongoing research,unassigned 2,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1287035&form=6&db=m Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1353102&form=6&db=m Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1376136&form=6&db=m HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1433262&form=6&db=m Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques. ongoing research,therapeutic application,unassigned 1,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1433500&form=6&db=m Sulfation of the human immunodeficiency virus envelope glycoprotein. ongoing research,unassigned 4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1493050&form=6&db=m Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells. therapeutic application,unassigned 2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1531159&form=6&db=m Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. ongoing research,therapeutic application,unassigned 3,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1588488&form=6&db=m A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: evidence for persistent cell-mediated immunity. ongoing research,therapeutic application,unassigned 1,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1611083&form=6&db=m Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. ongoing research,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1671940&form=6&db=m Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1678617&form=6&db=m Production of a novel antigen by conjugation of HIV-1 to Brucella abortus: studies of immunogenicity, isotype analysis, T-cell dependency, and syncytia inhibition. ongoing research,therapeutic application,unassigned 2,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1678778&form=6&db=m Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. ongoing research,unassigned 4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1692724&form=6&db=m Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I. ongoing research,therapeutic application,unassigned 3,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1706239&form=6&db=m Characterization and large production of human monoclonal antibodies against the HIV-1 envelope. ongoing research,therapeutic application,unassigned 3,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1722676&form=6&db=m Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1. ongoing research,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1727607&form=6&db=m Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells. ongoing research,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1742074&form=6&db=m Cross-neutralizing antibodies in rabbits immunized with HIV-1 gp160 purified from simian cells infected with a recombinant vaccinia virus. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1768463&form=6&db=m Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160. ongoing research,therapeutic application,unassigned 4,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1768464&form=6&db=m Cross-neutralizing antibodies to HIV-1 in mice after immunization with gp160 iscoms. Dissection of the immune response. ongoing research,unassigned 2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1915259&form=6&db=m Theoretical and functional analysis of the SIV fusion peptide. ongoing research,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1996409&form=6&db=m Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4. ongoing research,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2031689&form=6&db=m Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees. ongoing research,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2200748&form=6&db=m Response of monkeys to vaccination with recombinant vaccinia virus which coexpress HIV gp160 and human interleukin-2. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2238472&form=6&db=m The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing. therapeutic application,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2452443&form=6&db=m An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. ongoing research,unassigned 4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2476484&form=6&db=m Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120. diagnostic usage,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2536094&form=6&db=m Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera. ongoing research,therapeutic application,unassigned 3,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2713166&form=6&db=m Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity. ongoing research,therapeutic application,unassigned 3,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2905993&form=6&db=m HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus. ongoing research,therapeutic application,unassigned 3,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3146262&form=6&db=m Antibodies to soluble CD4 in HIV-1-infected individuals. diagnostic usage,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3162762&form=6&db=m A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3237686&form=6&db=m Improved antigenicity of the HIV env protein by cleavage site removal. ongoing research,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7490267&form=6&db=m Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase. ongoing research,therapeutic application,unassigned 2,4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7514675&form=6&db=m Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7515908&form=6&db=m Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction. therapeutic application,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7683694&form=6&db=m Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7688170&form=6&db=m Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7706435&form=6&db=m The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells. causal interaction,ongoing research,therapeutic application,unassigned 2,3,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7734199&form=6&db=m Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7745677&form=6&db=m Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion. ongoing research,unassigned 4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7782780&form=6&db=m The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. diagnostic usage,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7805733&form=6&db=m Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7893438&form=6&db=m Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques. therapeutic application,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7908700&form=6&db=m Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine. causal interaction,therapeutic application,unassigned 1,4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7930718&form=6&db=m Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 2,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7949087&form=6&db=m Syngeneic adoptive transfer of anti-human immunodeficiency virus (HIV-1)-primed lymphocytes from a vaccinated HIV-seronegative individual to his HIV-1-infected identical twin. ongoing research,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7957171&form=6&db=m Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor. unassigned - 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7975833&form=6&db=m Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8093218&form=6&db=m Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain. diagnostic usage,ongoing research,unassigned 1,4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8094248&form=6&db=m Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8095059&form=6&db=m Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. causal interaction,ongoing research,therapeutic application,unassigned 1,4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8179960&form=6&db=m Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18IIIB peptide in an HLA-A11-immunized individual. therapeutic application,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8198872&form=6&db=m Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. ongoing research,therapeutic application,unassigned 1,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8198873&form=6&db=m Production of long-lived neutralizing antibodies to HIV-1 IIIB in mice with a vaccinia recombinant virus-infected cell vaccine expressing gp160. diagnostic usage,ongoing research,therapeutic application,unassigned 1,4,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8245523&form=6&db=m Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8245524&form=6&db=m Cross-reactive response to human immunodeficiency virus type 1 (HIV-1) gp120 and HLA class I heavy chains induced by receipt of HIV-1-derived envelope vaccines. ongoing research,therapeutic application,unassigned 3,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8280475&form=6&db=m Role of HIV-1 envelope V3 loop cleavage in cell tropism. ongoing research,unassigned 4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8282780&form=6&db=m Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection. therapeutic application,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8296479&form=6&db=m Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41. ongoing research,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8411102&form=6&db=m Immunisation of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy. ongoing research,therapeutic application,unassigned 3,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8411113&form=6&db=m Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160. ongoing research,therapeutic application,unassigned 1,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8446603&form=6&db=m Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. ongoing research,therapeutic application,unassigned 4,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8460155&form=6&db=m Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8497051&form=6&db=m Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef. ongoing research,unassigned 4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8615025&form=6&db=m Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. ongoing research,unassigned 4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8627787&form=6&db=m Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice. diagnostic usage,therapeutic application,unassigned 3,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8906815&form=6&db=m Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160. therapeutic application,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8906986&form=6&db=m Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization. unassigned - 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9079699&form=6&db=m The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway. ongoing research,therapeutic application,unassigned 3,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9091063&form=6&db=m Lymphoproliferative response to synthetic V3 loop P18 peptide and HIV-1 envelope glycoprotein among individuals immunized with gp160 candidate vaccines. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9315483&form=6&db=m Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. therapeutic application,unassigned 2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9419172&form=6&db=m Persistent infection by Helicobacter pylori down-modulates virus-specific CD8+ cytotoxic T cell response and prolongs viral infection. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9465081&form=6&db=m Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. ongoing research,therapeutic application,unassigned 3,4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9733870&form=6&db=m Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein. therapeutic application,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10085412&form=6&db=m Enhanced HIV-1 envelope-tumor protection by a recombinant vaccinia virus expressing anchored HIV-1 gp120 lacking gp41. causal interaction,ongoing research,unassigned 3,4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10200293&form=6&db=m Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. ongoing research,therapeutic application,unassigned 3,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10384115&form=6&db=m A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL. diagnostic usage,ongoing research,unassigned 3,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10453506&form=6&db=m [HIV-1 env glycoprotein gp120 and gp160 expressed in vaccinia virus system and their antigenicity analysis] ongoing research,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10482571&form=6&db=m Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques. causal interaction,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10486104&form=6&db=m Recombinant vaccinia viruses expressing an immunodominant epitope of HIV-1 envelope protein within an influenza hemagglutinin cassette predominantly prime epitope-specific CD8(+) CTL. ongoing research,unassigned 4,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10501490&form=6&db=m The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus. ongoing research,therapeutic application,unassigned 1,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10648178&form=6&db=m Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein. causal interaction,ongoing research,therapeutic application,unassigned 1,2,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10798448&form=6&db=m Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization. ongoing research,unassigned 2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11062061&form=6&db=m Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication. causal interaction,ongoing research,therapeutic application,unassigned 1,3,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11067928&form=6&db=m Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity. ongoing research,therapeutic application,unassigned 1,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11101054&form=6&db=m Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques. ongoing research,therapeutic application,unassigned 2,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11180117&form=6&db=m Impaired development of HIV-1 gp160-specific CD8(+) cytotoxic T cells by a delayed switch from Th1 to Th2 cytokine phenotype in mice with Helicobacter pylori infection. unassigned - 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11249677&form=6&db=m Technology evaluation: HIVAC-1e. therapeutic application,unassigned 2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11294648&form=6&db=m Purification and characterization of a Ca2+-independent endoprotease activity from peripheral blood lymphocytes: involvement in HIV-1 gp160 maturation. ongoing research,unassigned 2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11441073&form=6&db=m Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody. diagnostic usage,therapeutic application,unassigned 1,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11818148&form=6&db=m Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein. ongoing research,unassigned 2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11932387&form=6&db=m Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12626740&form=6&db=m Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. diagnostic usage,therapeutic application,unassigned 1,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12792802&form=6&db=m The transmembrane domain of vesicular stomatitis virus glycoprotein suffices to anchor HIV-1 envelope gp120 expressed by a recombinant vaccinia virus. ongoing research,therapeutic application,unassigned 1,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14557642&form=6&db=m Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge. unassigned - 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14568947&form=6&db=m M cell DNA vaccination for CTL immunity to HIV. therapeutic application,unassigned 1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15057306&form=6&db=m Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. ongoing research,therapeutic application,unassigned 1,3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16081772&form=6&db=m Cutting edge: a single MHC class Ia is sufficient for CD8 memory T cell differentiation. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17959660&form=6&db=m Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. ongoing research,therapeutic application,unassigned 2,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20188679&form=6&db=m Co-administration of viral vector-based vaccines suppresses antigen-specific effector CD8 T cells. ongoing research,therapeutic application,unassigned 4,2,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21528538&form=6&db=m [The non-replicating recombinant vaccinia virus expressing six genes of HIV-1 can be passaged stably in CEF]. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22945875&form=6&db=m Induction of rapid apoptosis for class I MHC molecule-restricted CD8+ HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo. ongoing research,therapeutic application,unassigned 3,1,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23399840&form=6&db=m Induction of apoptosis-resistant and TGF-?-insensitive murine CD8(+) cytotoxic T lymphocytes specific for HIV-1 gp160. therapeutic application,unassigned 3,0 3.4.11.3 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27466414&form=6&db=m Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques. unassigned - 3.4.11.3 Vesicular Stomatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16060834&form=6&db=m Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. ongoing research,therapeutic application,unassigned 2,2,0 3.4.11.3 Vesicular Stomatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19264597&form=6&db=m Expression and processing of human immunodeficiency virus type 1 gp160 using the vesicular stomatitis virus New Jersey serotype vector system. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,1,0 3.4.11.3 Vesicular Stomatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26378177&form=6&db=m Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia. ongoing research,therapeutic application,unassigned 3,2,0 3.4.11.3 Viremia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9788675&form=6&db=m Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individuals. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Viremia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30842323&form=6&db=m Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract. unassigned - 3.4.11.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1674589&form=6&db=m A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. causal interaction,ongoing research,therapeutic application,unassigned 4,4,4,0 3.4.11.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8094248&form=6&db=m Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8995623&form=6&db=m The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells. ongoing research,unassigned 2,0 3.4.11.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9091063&form=6&db=m Lymphoproliferative response to synthetic V3 loop P18 peptide and HIV-1 envelope glycoprotein among individuals immunized with gp160 candidate vaccines. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,3,0 3.4.11.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9419172&form=6&db=m Persistent infection by Helicobacter pylori down-modulates virus-specific CD8+ cytotoxic T cell response and prolongs viral infection. diagnostic usage,ongoing research,unassigned 3,4,0 3.4.11.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12746459&form=6&db=m Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. causal interaction,ongoing research,unassigned 1,2,0 3.4.11.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15117456&form=6&db=m Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. ongoing research,therapeutic application,unassigned 4,1,0 3.4.11.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22896905&form=6&db=m Possible mechanism of action of antiviral proteins from the leaves of Chenopodium album L. causal interaction,unassigned 3,0